PDGFRbeta is an essential therapeutic target for BRCA1-deficient mammary tumors. Bai F, Liu S, Liu X, Hollern DP, et al. Breast Cancer Res 2021;23:10.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bai F, Liu S, Liu X, Hollern DP, et al. PDGFRbeta is an essential therapeutic target for BRCA1-deficient mammary tumors. Breast Cancer Res 2021;23:10.
PMID: 33478572